An injectable, dual-crosslinked polypeptide hydrogel encapsulating resiquimod-loaded nanoparticles as a long-lasting immunoprotective tumor vaccine
Jiaxuan Yang a b , Yijun Wu a b , Yunan Yuan a b , Fujiang Li a b , Ruonan Huang a b , Qian Cheng a b , Yan Rong a , Xuesi Chen a b , Chaoliang He
Journal of Controlled Release. 2026 Jun 10 .
Influencing factors:11.5
BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis
Ting Wu,Shuang Qi,Chenliang Shi,Chao Wu,Qingwang Liu,Chen Hu,Jie Hu,Aoli Wang,Jing Liu,Ziping Qi,Wenchao Wang,Qingsong Liu
Signal Transduct Target Ther. 2026 Apr 8 .
Influencing factors:52.7
Injection site dictates the immune response to a biodegradable polymer and corresponding collagen regeneration
Yanshuang Zhang , Tao Sun , Wenqian Li , Ye Fu , Yue Yu , Runjia Shen , Jiaqi Li , Lin Yu , Jiandong Ding
Bioactive Materials. 2026 Apr 8 .
Influencing factors:20.3
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma
Jiong-Liang Wang 1, Jun-Cheng Wang 1, Yangxun Pan 1, Minrui He 1, Zhikai Zheng 1, Hao Zou 1, Tianqing Wu 1, Yuhan Zhang 1, Zili Hu 1, Yizhen Fu 1, Wei Peng 1, Zhenyun Yang 1, Li Xu 1, Yao-Jun Zhang 1, Min-Shan Chen 1, Dandan Hu 1, Jinbin Chen 1, Ming Zhao 2, Dong-Ping Chen 3, Zhong-Guo Zhou
J Clin Invest. 2026 Apr 2 .
Influencing factors:13.6
3D-printed PRP-infused double-network hydrogels orchestrate inflammation resolution and vascular regeneration in infected wounds
Danlei Xing a b 1 , Zhiyuan Hu a 1 , Yue Tao a 1 , Hang Xia a 1 , Juanjuan Li c , Guoqing Xia d , Le Qiu a , Jie Shan a , Xiaojun Zha c , Xu-Lin Chen
Materials Today Bio. 2026 Apr 1 .
Influencing factors:10.2
Liver Kinase B1 in CD11c+ Cells Inhibits Fibrosis in Chronic Pancreatitis via the Oncostatin M Signaling
Wenqing Zhang 1, Shan Guo 1, Yu Zhang 1, He Ren 2, Ke Lei 3, Chenyang Zhao 3, Qian Yu 3, Hongqing Luo 1, Yujing Xiao 4, Xiaoming Feng 5, Xiaoyu Li
Adv Sci (Weinh). 2026 Mar 30 .
Influencing factors:14.1